Cigna Investments’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.37M | Buy |
16,201
+65
| +0.4% | +$11.8K | 0.31% | 56 |
|
|
2026
Q1 | $2.37M | Sell |
16,136
-161
| -1% | -$26.2K | 0.37% | 44 |
|
|
2025
Q4 | $3.18M | Buy |
16,297
+78
| +0.5% | +$18.6K | 0.46% | 31 |
|
|
2025
Q3 | $4.56M | Sell |
16,219
-94
| -0.6% | -$23.9K | 0.64% | 19 |
|
|
2025
Q2 | $3.57M | Buy |
16,313
+124
| +0.8% | +$20K | 0.61% | 24 |
|
|
2025
Q1 | $2.26M | Sell |
16,189
-45
| -0.3% | -$7.33K | 0.42% | 37 |
|
|
2024
Q4 | $2.71M | Sell |
16,234
-118
| -0.7% | -$21K | 0.47% | 29 |
|
|
2024
Q3 | $2.79M | Sell |
16,352
-197
| -1% | -$28.5K | 0.49% | 30 |
|
|
2024
Q2 | $2.34M | Buy |
16,549
+2
| +0% | +$248 | 0.43% | 35 |
|
|
2024
Q1 | $2.08M | Sell |
16,547
-110
| -0.7% | -$12.6K | 0.39% | 43 |
|
|
2023
Q4 | $1.76M | Buy |
16,657
+188
| +1% | +$20.5K | 0.36% | 49 |
|
|
2023
Q3 | $1.74M | Sell |
16,469
-2,134
| -11% | -$247K | 0.4% | 45 |
|
|
2023
Q2 | $2.22M | Sell |
18,603
-146
| -0.8% | -$15.1K | 0.41% | 44 |
|
|
2023
Q1 | $1.74M | Sell |
18,749
-387
| -2% | -$33.9K | 0.35% | 55 |
|
|
2022
Q4 | $1.56M | Buy |
19,136
+358
| +2% | +$27.2K | 0.32% | 62 |
|
|
2022
Q3 | $1.15M | Sell |
18,778
-1,029
| -5% | -$75.3K | 0.25% | 83 |
|
|
2022
Q2 | $1.38M | Sell |
19,807
-8,484
| -30% | -$621K | 0.28% | 73 |
|
|
2022
Q1 | $2.34M | Sell |
28,291
-8,661
| -23% | -$701K | 0.29% | 69 |
|
|
2021
Q4 | $3.22M | Sell |
36,952
-14,282
| -28% | -$1.34M | 0.25% | 67 |
|
|
2021
Q3 | $4.46M | Sell |
51,234
-5,301
| -9% | -$468K | 0.33% | 58 |
|
|
2021
Q2 | $4.4M | Sell |
56,535
-10,408
| -16% | -$815K | 0.31% | 62 |
|
|
2021
Q1 | $4.7M | Buy |
66,943
+535
| +0.8% | +$34.6K | 0.32% | 65 |
|
|
2020
Q4 | $4.3M | Buy |
66,408
+2,440
| +4% | +$145K | 0.33% | 61 |
|
|
2020
Q3 | $3.82M | Sell |
63,968
-24,473
| -28% | -$1.39M | 0.37% | 57 |
|
|
2020
Q2 | $4.89M | Buy |
88,441
+19,757
| +29% | +$1.05M | 0.46% | 41 |
|
|
2020
Q1 | $3.32M | Buy |
68,684
+11,832
| +21% | +$611K | 0.43% | 47 |
|
|
2019
Q4 | $2.98M | Sell |
56,852
-8,939
| -14% | -$492K | 0.32% | 65 |
|
|
2019
Q3 | $3.58M | Sell |
65,791
-2,696
| -4% | -$149K | 0.37% | 49 |
|
|
2019
Q2 | $3.86M | Sell |
68,487
-4,071
| -6% | -$220K | 0.42% | 42 |
|
|
2019
Q1 | $3.9M | Sell |
72,558
-4,063
| -5% | -$207K | 0.43% | 43 |
|
|
2018
Q4 | $3.46M | Sell |
76,621
-6,109
| -7% | -$293K | 0.29% | 49 |
|
|
2018
Q3 | $4.04M | Sell |
82,730
-11,098
| -12% | -$539K | 0.32% | 38 |
|
|
2018
Q2 | $4.13M | Sell |
93,828
-16,100
| -15% | -$742K | 0.3% | 41 |
|
|
2018
Q1 | $5.03M | Sell |
109,928
-1,151
| -1% | -$57.2K | 0.34% | 41 |
|
|
2017
Q4 | $5.25M | Sell |
111,079
-2,941
| -3% | -$144K | 0.34% | 40 |
|
|
2017
Q3 | $5.51M | Sell |
114,020
-1,091
| -0.9% | -$54.3K | 0.37% | 39 |
|
|
2017
Q2 | $5.77M | Sell |
115,111
-8,072
| -7% | -$368K | 0.4% | 35 |
|
|
2017
Q1 | $5.5M | Buy |
123,183
+10,696
| +10% | +$445K | 0.38% | 38 |
|
|
2016
Q4 | $4.33M | Buy |
+112,487
| New | +$4.4M | 0.47% | 37 |
|
Other funds holding ORCL
FWIA
Cigna Investments's ORCL Position: Q2 2026 in Review
Cigna Investments increased its Oracle (ORCL) stake by 0.4% in Q2 2026, buying an estimated $11.8K and bringing the position to 16,201 shares worth $2.37M. The position accounts for 0.31% of the portfolio, ranked #56.
Cigna Investments first reported a position in ORCL in Q4 2016 and has held it in 39 quarters since. The position peaked at $5.77M in Q2 2017. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.
- Cigna Investments held 16,201 shares of Oracle worth $2.37M as of Q2 2026.
- Cigna Investments bought 65 Oracle shares in Q2 2026, an estimated $11.8K.
- Oracle made up 0.31% of Cigna Investments's portfolio in Q2 2026, its #56 holding.
- Cigna Investments first reported a position in Oracle in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Oracle position peaked at $5.77M in Q2 2017.
- 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.